Navigation Links
The Medical Home: Building a Framework of Higher Quality, Reduced Cost and Patient-Centric Care
Date:2/6/2008

role of primary care physicians could mean short-term financial pain for hospitals and some health plans, and could aggravate the current manpower shortage without broadening the scope of ancillary providers' practice.

But the Center report, co-authored by Dr. Keckley and Dr. Howard R. Underwood of the Center, found that the long-range benefit is clear.

Pressure to adopt a medical home approach is driven by two critical, inter-connected factors - the shrinking number of primary care doctors due to difficult practice conditions and insufficient compensation, and the growing incidence/prevalence of chronic disease among the American population.

There is widespread recognition that the U.S. health care system falls short in its efforts to effectively manage chronic conditions, with some studies reporting care is sufficient only 55 percent of the time. Today, 45 percent of the population has a chronic medical condition. Among the Medicare population the statistics are even worse: 83 percent have at least one chronic condition and almost a quarter have at least five co-morbidities.

Related Content

Full Report: The Medical Home - Disruptive Innovation for a New Primary Care Model: http://www.deloitte.com/us/medicalhome

Overview: Deloitte Center for Health Solutions: http://www.deloitte.com/centerforhealthsolutions

Bio: Dr. Paul Keckley: http://www.deloitte.com/us/PaulKeckley

About Deloitte

As used in this document, "Deloitte" means Deloitte LLP, a subsidiary of Deloitte & Touche USA LLP. Please see http://www.deloitte.com/about for a detailed description of the legal structure of Deloitte & Touche USA LLP and its subsidiaries.
'/>"/>

SOURCE Deloitte
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13, 2008
2. Dr. Inder Verma named recipient of 2008 Vilcek Prize in biomedical science
3. MarketResearch.com Distributes Key Findings on Global Specialty Medical Beds and Therapeutic Surfaces Market
4. Margaret Dimond Named President and CEO of McLaren Medical Management Inc.
5. Rising Medical Solutions, Inc. Ranks Fifth on the Private Company Index (PCI) Top Growth Companies List
6. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds
7. Greenway Medical Technologies Continues Record Setting Growth
8. ReachMD and VerusMed Broadcast Medical Conference Coverage on XM Satellite Radio
9. Putting the Medical Profession on Notice!: Widow Tells Tragic Story of How Her Husband Died Due to Misdiagnosis and Mistreatment
10. SpringCM Improves Contract Management Efficiency for Medical Staffing Agency
11. Collaboration needed for strengthening medical research in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Immucor, Inc. (Nasdaq: BLUD ), a global leader ... industry, today announced that Paul D. Mintz, M.D. has ... director, effective January 1, 2010. ,, Dr. Mintz ... for more than 30 years. He is a tenured ... Virginia School of Medicine. He also serves as director ...
(Date:12/16/2009)... 16 The most widely used human embryonic stem ... social justice questions that must be addressed to ensure ... advances, according to a University of Michigan research team. ... the U-M team analyzed 47 embryonic stem cell lines, ... cell researchers. The scientists determined the genetic ancestry of ...
(Date:12/16/2009)... that increase susceptibility to disease , , WEDNESDAY, Dec. ... increased susceptibility to leprosy have been identified by ... who analyzed more than 10,000 DNA samples from ... their discovery highlights the important role that the ... leprosy. , "Though leprosy is not common, the ...
(Date:12/16/2009)... at work on a malaria elimination study in Africa ... the disease using cell phone records. , The scientists ... often residents of Zanzibar travel and where they go. ... coast of Tanzania in East Africa, Zanzibar has drastically ... study as part of deliberations on whether to launch ...
(Date:12/16/2009)... In animals, they cut bleeding time in half, but use ... (HealthDay News) -- Hoping to improve on nature, researchers have ... platelets, to be used in trauma or other cases where ... a core, with material that is used in degradable stitches, ... professor of biomedical engineering at Case Western Reserve University, and ...
Breaking Medicine News(10 mins):Health News:Immucor Appoints New Board Director 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:Leprosy Genes Identified 2Health News:Scientists use cell phone records to predict spread of malaria 2Health News:Scientists use cell phone records to predict spread of malaria 3Health News:Synthetic Platelets Put the Brakes on Blood Loss 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 3
... of coffee at breakfast may be making an individuals ... determine how caffeine impacts blood sugar control and insulin ... of instant coffee a day significantly impaired glucose tolerance ... have associated caffeine with decreased insulin sensitivity in young ...
... New research shows heart attacks without chest pain are more ... heart attack. Instead of chest pain //, some patients experience ... and vomiting. ,Researchers conducted a study to see how ... treated and how they recover. The study included information on ...
... shows , that older men are not the only ones ... Viagra (sildenafil) // users are men between ages 18 to ... insured males, ages 18 and older, from 1998 to 2002. ... study group, with men older than 56 years receiving the ...
... children with hemophilia arthropathy, a severe form of hemophilia ... risk // than other children for developing osteoporosis ... hope in preventing osteoporosis from hitting these children, say ... impact activities than was previously advised by doctors. An ...
... problem often leading to diabetes and cardiovascular disease. Being ... insulin resistant, but not all overweight or obese people ... insulin resistance, however, it is too difficult to administer ... come up with a simple way to identify overweight ...
... a prescription for a potentially lifesaving drug after a ... the heart has trouble pumping blood. // ... don’t receive an angiotensin-converting enzyme inhibitor are 14-percent more ... do get the drug. ACE inhibitors work by blocking ...
Other Medicine News:
(Date:12/16/2009)... -- Ethicon, Inc., a Johnson & Johnson (NYSE: ... leader in surgical care, and Acclarent, Inc., a ... developing and commercializing devices that address conditions affecting ... a definitive merger agreement whereby Ethicon will acquire ... million net of estimated cash on hand at ...
(Date:12/16/2009)... A new application developed by ... review of specialty pharmaceuticals has increased health plan ... while reducing costs. ,, AIM, a leading diagnostic ... plan clients representing over 35 million consumers and ... WLP ), adapted the successful clinical and ...
(Date:12/16/2009)... Dec. 16 Hospira, Inc. (NYSE: ... delivery company, today announced that it will host a ... results and projections for 2010 on Thursday, Feb. 4, ... will release its fourth-quarter and full-year 2009 results earlier ... the conference call. ,, A live webcast of the ...
Breaking Medicine Technology:Ethicon Announces Definitive Agreement to Acquire Acclarent 2Ethicon Announces Definitive Agreement to Acquire Acclarent 3Ethicon Announces Definitive Agreement to Acquire Acclarent 4American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4Hill Rom Investor Conference Features Business Strategy Updates and New Technologies 6993 1Hill Rom Investor Conference Features Business Strategy Updates and New Technologies 6993 2Hill Rom Investor Conference Features Business Strategy Updates and New Technologies 6993 3Hill Rom Investor Conference Features Business Strategy Updates and New Technologies 6993 4Hill Rom Investor Conference Features Business Strategy Updates and New Technologies 6993 5Hill Rom Investor Conference Features Business Strategy Updates and New Technologies 6993 6Hill Rom Investor Conference Features Business Strategy Updates and New Technologies 6993 7Masimo Chairman and CEO Joe Kiani Receives 2009 Frost 26amp 3B Sullivan CEO of the Year Award 6991 1Masimo Chairman and CEO Joe Kiani Receives 2009 Frost 26amp 3B Sullivan CEO of the Year Award 6991 2Masimo Chairman and CEO Joe Kiani Receives 2009 Frost 26amp 3B Sullivan CEO of the Year Award 6991 3Masimo Chairman and CEO Joe Kiani Receives 2009 Frost 26amp 3B Sullivan CEO of the Year Award 6991 4Masimo Chairman and CEO Joe Kiani Receives 2009 Frost 26amp 3B Sullivan CEO of the Year Award 6991 5Masimo Chairman and CEO Joe Kiani Receives 2009 Frost 26amp 3B Sullivan CEO of the Year Award 6991 6Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX 28R 29 in Multiple Breast Cancer Populations 6989 1Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX 28R 29 in Multiple Breast Cancer Populations 6989 2Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX 28R 29 in Multiple Breast Cancer Populations 6989 3Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX 28R 29 in Multiple Breast Cancer Populations 6989 4Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX 28R 29 in Multiple Breast Cancer Populations 6989 5Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX 28R 29 in Multiple Breast Cancer Populations 6989 6Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX 28R 29 in Multiple Breast Cancer Populations 6989 7
... Study, CHICAGO, June 01, 2007 /PRNewswire-FirstCall/ -- Statistics ... death in,African-Americans, with 21,550 new cases expected to ... devastating, lung,cancer is the leading cause of cancer ... of cancer death in Hispanic women.(ii),Researchers at Eli ...
... CBR of 52% which compares favorably with,the ... June 04, 2007 /PRNewswire-FirstCall/ - AEterna,Zentaris Inc. ... therapy and oncology, today announced that its ... 1 and,Phase 2 results for perifosine, an ...
Other Medicine Technology:Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 2Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 3Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 4Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 5Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 6Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 7Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 8Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 9Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 10Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer,Treatment 11AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 2AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 3AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results,for Anti-Cancer Compound Perifosine at ASCO Meeting 4
The Kowa Non-Contact Tonometer KT-800 comes with a one year parts and labor warranty....
The IR 1000 Insulin Infusion Pump from Animas offers unprecedented safety features, performance, and convenience....
... SpaTouch Pro, powered by LHE, ... multi-application platform. A powerful tool in ... works fast, providing noticeable results usually ... safety in each of its applications, ...
SPR treats pigmented and vascular lesions, skin aging, sun damaged skin and fine lines and wrinkles with clinically proven LHE technology....
Medicine Products: